The use of gastric content to predict poor outcomes in medical critically ill patients

• Conditions: gastric contentcritical illnessgastric pHpoor prognosisoutcomesproteomicsmetabolomics; gastric content; critical illness; gastric pH; poor prognosis; outcomes; proteomics; metabolomics

• Registration Number: TCTR20220530004
• Lead Sponsor: The Faculty of Medicine Research Fund

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-05-30
• Study Completion: 2023-01-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: nknown
• Sex: All
• Target Recruitment: 79

Inclusion Criteria

The patient who has nasogastric tube insertion on the first day of ICU admission.

Exclusion Criteria

The exclusion criteria are the patients who previously received PPIs or anti-histamine-2 receptor (H2RAS), unable to insert an NG tube on the first date, have upper GI bleeding, are pregnant, and refuse to participate in the study.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Composite outcomes of death, CDI, VAP, and SRMD 28 days proportion

Secondary Outcome Measures

Name	Time	Method
n/a n/a n/a